Chronic Lymphocytic Leukemia (CLL): evaluation of AKT protein kinase and microRNA gene expression related to disease pathogenesis. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 58, 2022. DOI: 10.1590/s2175-97902022e19946. Disponível em: https://www.revistas.usp.br/bjps/article/view/204545.. Acesso em: 9 may. 2024.